What is the precise immunopathobiologic mechanism of action for agents targeting IL-6 in the setting of RA? What are the implications for using IL-6 inhibitors as monotherapy?

What is the precise immunopathobiologic mechanism of action for agents targeting IL-6 in the setting of RA? What are the implications for using IL-6 inhibitors as monotherapy?

What is the precise immunopathobiologic mechanism of action for agents targeting IL-6 in the setting of RA? What are the implications for using IL-6 inhibitors as monotherapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Tom Huizinga, MD, PhD

Professor Tom Huizinga, MD, PhD

Head, Department of Rheumatology
Leiden University Medical Center
Leiden, The Netherlands